MedTrace Logo

Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

NCT01556126 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1191

Last updated 2021-07-20

No results posted yet for this study

Summary

The aim of this study is to evaluate safety and efficacy performances of CRE8 Drug Eluting Stent, in patients comparable to the everyday's clinical practice population, with a specific focus on diabetics, that will be part of a pre-specified study subgroup.

Conditions

  • Stable Angina
  • Unstable Angina
  • Acute Myocardial Infarction

Interventions

DEVICE

Amphilimus Eluting Stent (CRE8)

Sirolimus formulated coronary eluting stent

Sponsors & Collaborators

  • CID - Carbostent & Implantable Devices

    lead INDUSTRY

Principal Investigators

  • Antonio Colombo, MD · Fondazione San Raffaele del Monte Tabor

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-07-31
Completion
2018-12-31

Countries

  • Austria
  • Belgium
  • Italy
  • Netherlands
  • Norway
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01556126 on ClinicalTrials.gov